AtriCure (ATRC) Competitors

Teleflex (NYSE:TFX) and AtriCure (NASDAQ:ATRC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

Does the media prefer TFX or ATRC?

In the previous week, Teleflex had 2 more articles in the media than AtriCure. MarketBeat recorded 11 mentions for Teleflex and 9 mentions for AtriCure. Teleflex's average media sentiment score of 1.36 beat AtriCure's score of 0.97 indicating that Teleflex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Teleflex	7 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	5 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals believe in TFX or ATRC?

95.6% of Teleflex shares are held by institutional investors. Comparatively, 99.1% of AtriCure shares are held by institutional investors. 1.4% of Teleflex shares are held by company insiders. Comparatively, 3.5% of AtriCure shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Which has more risk and volatility, TFX or ATRC?

Teleflex has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500. Comparatively, AtriCure has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500.

Is TFX or ATRC more profitable?

Teleflex has a net margin of 6.31% compared to AtriCure's net margin of -7.27%. Teleflex's return on equity of 15.08% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Teleflex	6.31%	15.08%	8.85%
AtriCure	-7.27%	-4.20%	-3.19%

Do analysts prefer TFX or ATRC?

Teleflex presently has a consensus price target of $141.57, suggesting a potential upside of 17.00%. AtriCure has a consensus price target of $50.89, suggesting a potential upside of 43.55%. Given AtriCure's stronger consensus rating and higher probable upside, analysts clearly believe AtriCure is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1 Sell rating(s)	8 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
AtriCure	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has preferable earnings & valuation, TFX or ATRC?

Teleflex has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$3.05B	1.75	$69.68M	$4.25	28.47
AtriCure	$465.31M	3.79	-$44.70M	-$0.77	-46.04

Summary

Teleflex beats AtriCure on 9 of the 16 factors compared between the two stocks.